Advertisement
Screener

PEAK PHARMACEUTICALS, INC. (RMHI) Unrealized Gain (Loss) on Investments

PEAK PHARMACEUTICALS, INC. Unrealized Gain (Loss) on Investments

PEAK PHARMACEUTICALS, INC. (RMHI) reported Unrealized Gain (Loss) on Investments of $5.00 thousand for the 12-month period ending 2018-09-30, per its 10-K filed 2022-12-19.

Discontinued › Cash Flow › Operating Activities

us-gaap:UnrealizedGainLossOnInvestments · last filed 2022-12-19

  • PEAK PHARMACEUTICALS, INC. unrealized gain (loss) on investments for the quarter ending 2017-09-30 was -$10.00K.
  • PEAK PHARMACEUTICALS, INC. unrealized gain (loss) on investments for the quarter ending 2017-06-30 was $0.00.
  • PEAK PHARMACEUTICALS, INC. unrealized gain (loss) on investments for the quarter ending 2016-06-30 was $0.00.
  • PEAK PHARMACEUTICALS, INC. unrealized gain (loss) on investments for fiscal 2018 was $5.00K.
  • PEAK PHARMACEUTICALS, INC. unrealized gain (loss) on investments for fiscal 2017 was -$5.00K.
Period endUnrealized Gain (Loss) on Investments 3 monthUnrealized Gain (Loss) on Investments 6 monthUnrealized Gain (Loss) on Investments 9 monthUnrealized Gain (Loss) on Investments 12 month
2018-09-30$5.00K
10-K · filed 2022-12-19
2017-09-30-$10.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-19
-$10.00K
derived: sum of 2 quarters · filed 2022-12-19
-$5.00K
10-K · filed 2022-12-19
2017-06-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-13
$5.00K
10-Q · filed 2017-09-13
2017-03-31$5.00K
10-Q · filed 2017-09-13
2016-06-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-13
$0.00
10-Q · filed 2017-09-13
2016-03-31$0.00
10-Q · filed 2017-09-13